An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer.
Susan CostantiniAndrea PoloFrancesca CaponeMarina AccardoAngela SoriceRita LombardiPalmina BagnaraFederica Zito MarinoMartina AmatoMichele OrdituraMaddalena FratelliGennaro CilibertoAlfredo BudillonPublished in: Cancers (2022)
Combined evaluation of SELENOS and VCP/p97 might represent a novel potential prognostic signature and a therapeutic target to be exploited in TNBC.